BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• BioCapital

  Sapio Sciences Launches New Multimodal Registration Capabilities For Its Lab Informatics Platform

  Sapio Sciences has enhanced its lab informatics platform with new multimodal entity registration capabilities for diverse product types, including small and large molecules and conjugates.

  April 23, 2024

   · 

  3 min read
• Business

  Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

  Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its first quarter 2024 financial results on Tuesday, May 7, 2024 before market open.

  April 23, 2024

   · 

  1 min read
• Business

  Seamless Therapeutics Announces New CEO and Board Chairman to Support US Expansion of Programmable Recombinase Gene Editing Technology Platform

  Seamless Therapeutics today announced the appointments of Albert Seymour, Ph.D., as its new President and Chief Executive Officer and Adam Rosenberg as Independent Chairman of the company’s Board of Directors.

  April 23, 2024

   · 

  5 min read
• Genetown

  hC Bioscience Announces Lead Program in Hemophilia and Reports Positive Preclinical Data on Novel Protein Editing Approach Using Anticodon Engineered tRNA

  hC Bioscience today announced preclinical data supporting its lead program in severe hemophilia A at the World Federation of Hemophilia 2024 World Congress in Madrid, Spain.

  April 23, 2024

   · 

  2 min read
• Business

  908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024

  908 Devices Inc. today announced it will report financial results for the first quarter 2024 before market open on Tuesday, April 30, 2024.

  April 23, 2024

   · 

  1 min read
• BioCapital

  The National Kidney Foundation Urges Passage of New Home Dialysis Bill

  The National Kidney Foundation is applauding a move by Congress to increase access to care and improve outcomes for some patients on dialysis.

  April 23, 2024

   · 

  5 min read
• ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

  ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management.

  April 23, 2024

   · 

  5 min read
• Biotech Bay

  Encoded Therapeutics Provides Pipeline Updates From Its Vector Engineering Platform Ahead of Four Preclinical Presentations at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

  Encoded Therapeutics Provides Pipeline Updates From Its Vector Engineering Platform Ahead of Four Preclinical Presentations at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT).

  April 23, 2024

   · 

  5 min read
• Deals

  Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists

  Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists.

  April 23, 2024

   · 

  8 min read
• Biotech Beach

  Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24

  Calidi Biotherapeutics Inc. is pleased to invite investors to a webinar on April 24, 2024 at 4:15 p.m. ET.

  April 23, 2024

   · 

  3 min read